Literature DB >> 20369076

Calcitonin gene-related peptide: A molecular link between obesity and migraine?

Ana Recober1, Peter J Goadsby.   

Abstract

Epidemiological studies have begun to suggest obesity is a risk factor for chronic migraine, although no causal relationship has been established and risk factors for progression from episodic to chronic migraine remain unknown. The neuropeptide calcitonin gene-related peptide (CGRP) plays a important role in the pathophysiology of migraine. Here, the potential role of CGRP as a molecular link between obesity and migraine is reviewed. A mechanistic association is supported by several lines of evidence: 1) common markers are elevated in obesity and migraine, 2) adipose tissue secretes proinflammatory cytokines and adipocytokines that have been implicated in migraine pathophysiology and 3) elevated levels of CGRP have been found in plasma of obese individuals. We propose that CGRP released from trigeminal neurons may represent a biological link between obesity and migraine. Enhanced trigeminal CGRP production in obese susceptible individuals may lower the threshold necessary to trigger migraine attacks, leading to more frequent episodes and eventually to chronic migraine. Copyright 2010 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20369076      PMCID: PMC2947336          DOI: 10.1358/dnp.2010.23.2.1475909

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  69 in total

1.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

2.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation.

Authors:  J McCulloch; R Uddman; T A Kingman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Transformed or evolutive migraine.

Authors:  N T Mathew; U Reuveni; F Perez
Journal:  Headache       Date:  1987-02       Impact factor: 5.887

4.  Calcitonin gene-related peptide levels are elevated in patients with sepsis.

Authors:  C D Joyce; R R Fiscus; X Wang; D J Dries; R C Morris; R A Prinz
Journal:  Surgery       Date:  1990-12       Impact factor: 3.982

5.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

6.  Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide.

Authors:  J Hosoi; G F Murphy; C L Egan; E A Lerner; S Grabbe; A Asahina; R D Granstein
Journal:  Nature       Date:  1993-05-13       Impact factor: 49.962

7.  Calcitonin gene-related peptide in human obesity.

Authors:  P M Zelissen; H P Koppeschaar; C J Lips; W H Hackeng
Journal:  Peptides       Date:  1991 Jul-Aug       Impact factor: 3.750

Review 8.  Calcitonin gene-related peptide and its role in migraine pathophysiology.

Authors:  Udayasankar Arulmani; Antoinette Maassenvandenbrink; Carlos M Villalón; Pramod R Saxena
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

View more
  17 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Lifestyle Factors and Migraine in Childhood.

Authors:  Antonio Russo; Antonio Bruno; Francesca Trojsi; Alessandro Tessitore; Gioacchino Tedeschi
Journal:  Curr Pain Headache Rep       Date:  2016-02

3.  Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury.

Authors:  Brittany V Daiutolo; Ashley Tyburski; Shannon W Clark; Melanie B Elliott
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

Review 4.  Association Between Obesity and Migraine in Women.

Authors:  Jelena M Pavlovic; Julio R Vieira; Richard B Lipton; Dale S Bond
Journal:  Curr Pain Headache Rep       Date:  2017-08-25

Review 5.  Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.

Authors:  Maria Gabriella Saracco; Gianni Allais; Vincenzo Tullo; Dario Zava; Deborha Pezzola; Giorgio Reggiardo; Stefano Omboni; Chiara Benedetto; Gennaro Bussone; Marco Aguggia
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 6.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 7.  Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms.

Authors:  Raiza Bonomo; Sarah Kramer; Virginie M Aubert
Journal:  Antioxid Redox Signal       Date:  2022-05-23       Impact factor: 7.468

8.  Effects of diet-induced obesity on motivation and pain behavior in an operant assay.

Authors:  H L Rossi; A K S Luu; S D Kothari; A Kuburas; J K Neubert; R M Caudle; A Recober
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 9.  Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Authors:  Eduardo Rivera-Mancilla; Linda Al-Hassany; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

10.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.